TY - JOUR
T1 - Left ventricular myocardial adenosine triphosphate changes during reperfusion of ventricular fibrillation
T2 - The influence of flow and epinephrine
AU - Angelos, Mark G.
AU - Torres, Carlos A.A.
AU - Waite, Michael D.
AU - Rath, Dipti P.
AU - Zhu, Hui
AU - Beckley, Philip D.
AU - Palmer, Brian S.
AU - Robitaille, Pierre Marie L.
PY - 2000
Y1 - 2000
N2 - Objective: To determine whether epinephrine in combination with high flow worsens left ventricular (LV) myocardial high-energy phosphate stores during reperfusion of ischemic ventricular fibrillation (V/F). Design: Blinded, prospective block randomized, placebo controlled study. Setting: University medical center research laboratory. Subjects: A total of 22 mixed breed swine weighing 22.0 ± 3.3 kg (SD). Interventions: Open-chest swine, anesthetized with α-chloralose, underwent 10 mins of nonperfused VF followed by reperfusion with cardiopulmonary bypass for 90 mins and then defibrillation. Animals were block randomized to four groups for reperfusion: Group 1 (n = 5), high flow (100 mL/kg/min) and epinephrine (2.5 μg/kg/min); Group 2 (n = 5), high flow and placebo; Group 3 (n = 6), low flow (30 mL/kg/min) and epinephrine; and Group 4 (n = 6), low flow and placebo. Measurements and Main Results: In vivo LV creatine phosphate (CP) and adenosine triphosphate (ATP) were determined using whole wall and spatially localized 31P NMR spectroscopy at 4.7 Tesla. During perfusion of the fibrillating myocardium, epinephrine significantly increased aortic pressure (p < .05) and improved defibrillation rates (p < .01). ATP levels during reperfusion were significantly decreased within all groups compared with baseline. There were no differences in ATP levels between groups. High flow, independent of epinephrine, was associated with increased preservation of ATP (p < .05), increased CP/ATP ratios (p < .02) in all layers of the LV wall, and decreased aortic and cardiac vein lactates (p < .001). Conclusions: Epinephrine, in combination with flow higher than standard cardiopulmonary resuscitation flows, increased perfusion pressure and defibrillation rates, but did not significantly alter myocardial ATP during VF reperfusion in the in vivo heart. Reperfusion flow, independent of epinephrine, is a critical determinant of myocardial ATP preservation.
AB - Objective: To determine whether epinephrine in combination with high flow worsens left ventricular (LV) myocardial high-energy phosphate stores during reperfusion of ischemic ventricular fibrillation (V/F). Design: Blinded, prospective block randomized, placebo controlled study. Setting: University medical center research laboratory. Subjects: A total of 22 mixed breed swine weighing 22.0 ± 3.3 kg (SD). Interventions: Open-chest swine, anesthetized with α-chloralose, underwent 10 mins of nonperfused VF followed by reperfusion with cardiopulmonary bypass for 90 mins and then defibrillation. Animals were block randomized to four groups for reperfusion: Group 1 (n = 5), high flow (100 mL/kg/min) and epinephrine (2.5 μg/kg/min); Group 2 (n = 5), high flow and placebo; Group 3 (n = 6), low flow (30 mL/kg/min) and epinephrine; and Group 4 (n = 6), low flow and placebo. Measurements and Main Results: In vivo LV creatine phosphate (CP) and adenosine triphosphate (ATP) were determined using whole wall and spatially localized 31P NMR spectroscopy at 4.7 Tesla. During perfusion of the fibrillating myocardium, epinephrine significantly increased aortic pressure (p < .05) and improved defibrillation rates (p < .01). ATP levels during reperfusion were significantly decreased within all groups compared with baseline. There were no differences in ATP levels between groups. High flow, independent of epinephrine, was associated with increased preservation of ATP (p < .05), increased CP/ATP ratios (p < .02) in all layers of the LV wall, and decreased aortic and cardiac vein lactates (p < .001). Conclusions: Epinephrine, in combination with flow higher than standard cardiopulmonary resuscitation flows, increased perfusion pressure and defibrillation rates, but did not significantly alter myocardial ATP during VF reperfusion in the in vivo heart. Reperfusion flow, independent of epinephrine, is a critical determinant of myocardial ATP preservation.
KW - Adenosine triphosphate
KW - Creatine phosphate
KW - Epinephrine
KW - Left ventricle
KW - Metabolism
KW - Phosphates
KW - Porcine
KW - Spectroscopy
KW - Ventricular fibrillation
UR - http://www.scopus.com/inward/record.url?scp=0034081545&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034081545&partnerID=8YFLogxK
U2 - 10.1097/00003246-200005000-00041
DO - 10.1097/00003246-200005000-00041
M3 - Article
C2 - 10834703
AN - SCOPUS:0034081545
SN - 0090-3493
VL - 28
SP - 1503
EP - 1508
JO - Critical care medicine
JF - Critical care medicine
IS - 5
ER -